The fact that TAP-deficient B7.1-expressing tumor cells can generate a CD8+ T-cell mediated immune response against TAP-negative tumor cells suggests that the tumor cells present TAP-independent antigen(s) for T-cell priming. The gene discussed is CD80; the disease is neoplasm.